Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hypersensitivity Reaction

Free Subscription Articles published in Respir Med Retrieve available abstracts of 140 articles: HTML format

Single Articles

November 2025
1. CHEN L, Chen H, Chen Z, Zhang K, et al
   Visceral obesity, partly mediated by a reduction in HDL-C, increases the risk of asthma: Insights from NHANES and Mendelian randomization studies.
   Respir Med. 2025;249:108482.
   PubMed     Abstract available
   
   
   
2. QIN L, Na L, Liu JL, Tang LF, et al
   Risk factors and strategies associated with subcutaneous allergen immunotherapy in children.
   Respir Med. 2025 Nov 4:108461. doi: 10.1016/j.rmed.2025.108461.
   PubMed     Abstract available
   
   
   
3. ZHANG S, Shen K, Sun B, Liu B, et al
   Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
   Respir Med. 2025;248:108422.
   PubMed     Abstract available
   
   
   
4. TAHMAZ T, Aslan GK, Yeldan I, Okumus NG, et al
   Comparison of the effects of one-legged and two-legged exercise training on exercise capacity and fatigue in patients with sarcoidosis.
   Respir Med. 2025;248:108380.
   PubMed     Abstract available
   
   
   
5. LUO W, Zheng X, Zhang J, Li A, et al
   Component-resolved diagnostics study on nut sensitization and cross-reactivity in China.
   Respir Med. 2025;248:108365.
   PubMed     Abstract available
   
   
   
6. CAZZOLA M, Hanania NA, Rogliani P
   Comorbidities as treatable traits of chronic airway diseases.
   Respir Med. 2025;248:108333.
   PubMed     Abstract available
   
   
   
7. AGUSTI A, Gibson P, Cazzola M
   Treatable Traits. Why, What, How?
   Respir Med. 2025;249:108421.
   PubMed     Abstract available
   
   
   October 2025
8. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
   Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
   Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
   PubMed     Abstract available
   
   
   
9. MACKLE R, Crespo-Gonzalez C, Gray M, Chan M, et al
   Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals.
   Respir Med. 2025;249:108444.
   PubMed     Abstract available
   
   
   
10. DA SILVA LIMA D, Rechenmacher C, Bernardi J, Velleda de Morais R, et al
    SMAD3 gene methylation profile and asthma in childhood: A longitudinal approach.
    Respir Med. 2025;249:108424.
    PubMed     Abstract available
    
    
    
11. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    PubMed     Abstract available
    
    
    
12. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    PubMed     Abstract available
    
    
    
13. OTTEN B, Weinberg D, Gregoski MJ, James WE, et al
    Management of anti-drug antibodies against TNF-inhibitors in sarcoidosis patients.
    Respir Med. 2025;247:108301.
    PubMed     Abstract available
    
    
    
14. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    PubMed     Abstract available
    
    
    September 2025
15. BROZEK G, Nowak B, Prendergast C, Gil A, et al
    Thirty year trends in childhood asthma and allergic conditions in Poland.
    Respir Med. 2025;248:108379.
    PubMed     Abstract available
    
    
    
16. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    PubMed     Abstract available
    
    
    
17. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    PubMed     Abstract available
    
    
    
18. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    PubMed     Abstract available
    
    
    
19. ZHOU Y, Yao Q, Chen X, Yu D, et al
    Airway involvement in pulmonary sarcoidosis: Clinical and CT features.
    Respir Med. 2025;246:108207.
    PubMed     Abstract available
    
    
    August 2025
20. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    PubMed     Abstract available
    
    
    
21. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    PubMed     Abstract available
    
    
    
22. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    PubMed     Abstract available
    
    
    
23. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    PubMed     Abstract available
    
    
    
24. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    PubMed     Abstract available
    
    
    
25. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    PubMed     Abstract available
    
    
    
26. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    PubMed     Abstract available
    
    
    
27. PHAM TQ, Delorme L, Cortaredona S, Ranque S, et al
    Pulmonary Aspergillosis: Epidemiology and unresolved diagnostic challenges - insights from a two-year retrospective cohort study in Marseille.
    Respir Med. 2025;245:108206.
    PubMed     Abstract available
    
    
    
28. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    PubMed     Abstract available
    
    
    July 2025
29. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    PubMed     Abstract available
    
    
    
30. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    PubMed     Abstract available
    
    
    
31. TIAN C, Xiong S, Song X, Li S, et al
    Spirometry and impulse oscillometry in the diagnosis of cough variant asthma in children.
    Respir Med. 2025;246:108255.
    PubMed     Abstract available
    
    
    
32. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    PubMed     Abstract available
    
    
    
33. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    PubMed    
    
    
    
34. KISIEL MA, Zhou X, Fundberg I, Barrling A, et al
    Mortality and its predictive factors in participants with asthma: a 26-year follow-up.
    Respir Med. 2025;246:108253.
    PubMed     Abstract available
    
    
    
35. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    PubMed     Abstract available
    
    
    
36. DIEZ SIERRA J, Medina Gallardo JF, Munoz Sanchez B, Leon Lloreda A, et al
    FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor.
    Respir Med. 2025 Jul 4:108247. doi: 10.1016/j.rmed.2025.108247.
    PubMed     Abstract available
    
    
    
37. ALIPOUR P, Nery PB, Beanlands RS, Wiefels C, et al
    Durable remission of cardiac sarcoidosis following discontinuation of methotrexate: A prospective cohort study.
    Respir Med. 2025;243:108126.
    PubMed     Abstract available
    
    
    
38. HANSEN H, Godtfredsen N, Ulrik CS, Hansen J, et al
    Physical activity levels in Danish adults with and without asthma - A national recurrent cross-sectional case-control study from 2010 to 2021.
    Respir Med. 2025 Jul 1:108240. doi: 10.1016/j.rmed.2025.108240.
    PubMed     Abstract available
    
    
    June 2025
39. ZHU W, Chen K, Xiang Y, Shi J, et al
    Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis.
    Respir Med. 2025 Jun 26:108223. doi: 10.1016/j.rmed.2025.108223.
    PubMed     Abstract available
    
    
    
40. ANTAO J, Rodrigues G, Deng Q, Baak BN, et al
    Trends in initial pharmacological treatment of asthma in primary care (2010-2021): A population-based study using the PHARMO data network.
    Respir Med. 2025;246:108222.
    PubMed     Abstract available
    
    
    
41. ZHENG X, Jiang H, Cui R, Cai A, et al
    From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.
    Respir Med. 2025 Jun 13:108212. doi: 10.1016/j.rmed.2025.108212.
    PubMed     Abstract available
    
    
    
42. HANSEN S, Hakansson KEJ, Soendergaard MB, Bjerrum AS, et al
    Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
    Respir Med. 2025 Jun 11:108203. doi: 10.1016/j.rmed.2025.108203.
    PubMed     Abstract available
    
    
    
43. PINI L, Caminati M, Maule M, Bagnasco D, et al
    ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
    Respir Med. 2025;245:108198.
    PubMed     Abstract available
    
    
    
44. BRAUNWALDER C, Ertl J, Wullschleger M, Timm E, et al
    Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: A systematic review.
    Respir Med. 2025 Jun 7:108202. doi: 10.1016/j.rmed.2025.108202.
    PubMed     Abstract available
    
    
    
45. TAY TR, Pang E, Liew MF, Tiew PY, et al
    Ethnic variation in South East Asian patients with Severe Asthma: A First Look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice.
    Respir Med. 2025 Jun 5:108199. doi: 10.1016/j.rmed.2025.108199.
    PubMed     Abstract available
    
    
    
46. COOPER DH, Akbarian N, Aaron SD, Luks V, et al
    Glucagon-like Peptide 1 (GLP-1) Receptor Agonists and Asthma and COPD Exacerbations in Adults with Diabetes: A Systematic Review.
    Respir Med. 2025 Jun 4:108197. doi: 10.1016/j.rmed.2025.108197.
    PubMed     Abstract available
    
    
    
47. LI H, Huang X, Wei Z, Chen Z, et al
    Unveiling genetic links: GSDMB polymorphisms and asthma susceptibility in the Zhuang Nationality of Guangxi.
    Respir Med. 2025;245:108176.
    PubMed     Abstract available
    
    
    May 2025
48. HANANIA NA, Stanford R, Rendon A, Gemicioglu B, et al
    Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis.
    Respir Med. 2025 May 28:108172. doi: 10.1016/j.rmed.2025.108172.
    PubMed     Abstract available
    
    
    
49. ZHANG X, Zhang X, Wan Y, Xu D, et al
    The association between alpha-1-acid glycoprotein and asthma in United States: a cross-sectional study from NHANES.
    Respir Med. 2025;245:108174.
    PubMed     Abstract available
    
    
    
50. COTTINI M, Poto R, Bhattacharjee A, Galant S, et al
    Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
    Respir Med. 2025 May 27:108180. doi: 10.1016/j.rmed.2025.108180.
    PubMed     Abstract available
    
    
    
51. XIANG J, Cui M
    Neutrophil Extracellular Traps and neutrophilic asthma.
    Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
    PubMed     Abstract available
    
    
    
52. LEMACON C, Lopes AA
    Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
    Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
    PubMed     Abstract available
    
    
    
53. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
    High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
    Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
    PubMed     Abstract available
    
    
    
54. WENNERGREN G, Lindberg A, Kauppi P, Kankaanranta H, et al
    Glimpses of diagnostic tools and treatment of asthma in Sweden, Norway, and Finland from a medico-historical perspective.
    Respir Med. 2025;243:108139.
    PubMed     Abstract available
    
    
    
55. BULKHI AA, Elkkari A, Alghamdi BJ, Mahboub B, et al
    Defining Clinical Remission in Severe Asthma: Expert Opinion from the Gulf Region Using the Modified Delphi Method.
    Respir Med. 2025 May 3:108132. doi: 10.1016/j.rmed.2025.108132.
    PubMed     Abstract available
    
    
    
56. DEHARA M, Nguyen NV, Arkema EV
    Smoking and the risk of sarcoidosis: a systematic review and meta-analysis.
    Respir Med. 2025;241:108089.
    PubMed     Abstract available
    
    
    
57. LUNDE AG, Henriksen AH, Sorger H, Naustdal T, et al
    Prevalence, incidence, and mortality associated with sarcoidosis over three decades in the HUNT Study in Norway.
    Respir Med. 2025;241:108049.
    PubMed     Abstract available
    
    
    April 2025
58. TSE SM, Babatounde AK, Drouin O, Radhakrishnan D, et al
    The association between the stringency of COVID-19 public health mitigation strategies and pediatric asthma-related hospitalizations in Canada: an ecological study over 2 years.
    Respir Med. 2025;243:108125.
    PubMed     Abstract available
    
    
    
59. HUETHER KM, Lamb JM, Skelly J, Brigham E, et al
    Omega-3 Fatty Acid Intake Potentiates Bronchodilator Response in Patients with Obesity and Poorly Controlled Asthma.
    Respir Med. 2025 Apr 26:108131. doi: 10.1016/j.rmed.2025.108131.
    PubMed     Abstract available
    
    
    
60. GHERASIM A, Dietsch F, Odul F, Riff T, et al
    Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
    Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
    PubMed     Abstract available
    
    
    
61. UNSAL H, Karaguzel D, Sarac BE, Aytekin ES, et al
    Inflammatory and oxidative stress markers in serum, urine and exhaled breath condensate: Relationship between asthma and obesity in children.
    Respir Med. 2025;242:108096.
    PubMed     Abstract available
    
    
    
62. BAGUST A, Zhao C, Troy L, Van Buskirk J, et al
    Geographic variability of interstitial lung disease diagnoses and impact of air pollution on disease outcomes.
    Respir Med. 2025;239:107996.
    PubMed     Abstract available
    
    
    
63. DY ABC, Voraphani N, Spangenberg A, Belinsky SA, et al
    Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study.
    Respir Med. 2025;240:108044.
    PubMed     Abstract available
    
    
    
64. ZHANG S, Lin J
    Association of circadian syndrome and lung health: A population-based cohort study.
    Respir Med. 2025;240:108031.
    PubMed     Abstract available
    
    
    March 2025
65. STATEN T, Liu PH, Holt C, Alismail A, et al
    Effectiveness Of A Respiratory Therapist-Led, Community-Based Asthma Program In An Under resourced Rural Border Town In California.
    Respir Med. 2025 Mar 29:108071. doi: 10.1016/j.rmed.2025.108071.
    PubMed     Abstract available
    
    
    
66. MENZELLA F, Cottini M, Lombardi C, Senna G, et al
    A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction.
    Respir Med. 2025 Mar 25:108054. doi: 10.1016/j.rmed.2025.108054.
    PubMed     Abstract available
    
    
    
67. ECK S, Baumgartel A, Hapfelmeier A, Linde K, et al
    Effectiveness of an online asthma education program in adults with asthma in general practice: Results from a cluster randomised controlled trial.
    Respir Med. 2025;240:108041.
    PubMed     Abstract available
    
    
    
68. GUINOSSI RM, Bertagni Mingotti CF, Burch MO, Teixeira Soares LA, et al
    Residential greenness, respiratory symptoms and lung function in children, adolescents and adults with asthma: a cross-sectional study.
    Respir Med. 2025 Mar 11:108038. doi: 10.1016/j.rmed.2025.108038.
    PubMed     Abstract available
    
    
    
69. PELGROM AT, de Jongh IFHC, van den Aardweg JG, van Veen IHPAA, et al
    Analysis of the breathing pattern in patients with asthma during physical exercise: a cross-sectional study.
    Respir Med. 2025 Mar 11:108037. doi: 10.1016/j.rmed.2025.108037.
    PubMed     Abstract available
    
    
    
70. ORTIZ J, Staggers KA, Adrish M, Hanania NA, et al
    Asthma outcomes in a safety net hospital system: A comparative study to a national cohort.
    Respir Med. 2025;240:108032.
    PubMed     Abstract available
    
    
    
71. ZHAO C, Wang L, Zhang L, Wang Q, et al
    Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes.
    Respir Med. 2025 Mar 3:108024. doi: 10.1016/j.rmed.2025.108024.
    PubMed     Abstract available
    
    
    
72. OTTESEN TG, Rovsing AH, Ulrik CS
    Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
    Respir Med. 2025;238:107962.
    PubMed     Abstract available
    
    
    
73. KINOSHITA Y, Hirai C, Hara K, Takenaka S, et al
    Diagnostic and prognostic implications of a deep suprasternal notch in idiopathic pleuroparenchymal fibroelastosis.
    Respir Med. 2025;238:107986.
    PubMed     Abstract available
    
    
    
74. NAKAMURA J, Sato T, Ohira H, Yoshikawa S, et al
    Prevalence, incidence, and clinical features of cardiac involvement in patients with pulmonary sarcoidosis.
    Respir Med. 2025;238:107954.
    PubMed     Abstract available
    
    
    February 2025
75. SUN C, Li N, Xiao X, Zhang Q, et al
    Association between lipid accumulation products and asthma among adults: Data from National Health and Nutrition Examination Survey (NHANES) 2003-2018.
    Respir Med. 2025;240:108017.
    PubMed     Abstract available
    
    
    
76. PORTACCI A, Iorillo I, Quaranta VN, Amendolara M, et al
    Diaphragm function in patients with asthma and healthy controls: a cross-sectional study.
    Respir Med. 2025 Feb 18:108008. doi: 10.1016/j.rmed.2025.108008.
    PubMed     Abstract available
    
    
    
77. JIANG P, Lu H, Jiang Y, Li F, et al
    Association between the triglyceride-glucose index and mortality in the asthma population.
    Respir Med. 2025 Feb 8:107989. doi: 10.1016/j.rmed.2025.107989.
    PubMed     Abstract available
    
    
    
78. GARCIA-MOGUEL I, Martinez-Mesa A, Andujar-Espinosa R, Diaz-Campos R, et al
    The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis.
    Respir Med. 2025;237:107940.
    PubMed     Abstract available
    
    
    
79. SAPORITI JM, de Holanda TA, Torino GG, Boscato N, et al
    Obstructive sleep apnoea-associated factors in children and adolescents diagnosed by polysomnography: A scoping review.
    Respir Med. 2025;237:107942.
    PubMed     Abstract available
    
    
    January 2025
80. TIOTIU A, Migueres N, Gonzalez-Barcala FJ, Roux P, et al
    Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps.
    Respir Med. 2025;238:107979.
    PubMed     Abstract available
    
    
    
81. OKAY B, Hatipoglu HU, Okay ZU, Sahin K, et al
    COMPARING MESH AND COMPRESSOR NEBULIZERS IN PULMONARY FUNCTION TEST IN PEDIATRIC ASTHMA ATTACKS: A DOUBLE-BLIND RANDOMIZED COMPARATIVE CLINICAL TRIAL.
    Respir Med. 2025 Jan 28:107966. doi: 10.1016/j.rmed.2025.107966.
    PubMed     Abstract available
    
    
    
82. CAZZOLA M, Calzetta L, Matera MG, Rogliani P, et al
    Challenges in treating patients with comorbid asthma and bronchiectasis.
    Respir Med. 2025 Jan 21:107957. doi: 10.1016/j.rmed.2025.107957.
    PubMed     Abstract available
    
    
    
83. COSINI FF, Bagnasco D, Braido F, Canonica GW, et al
    Background therapy in severe asthma on monoclonal antibody treatment in real life.
    Respir Med. 2025;237:107944.
    PubMed     Abstract available
    
    
    December 2024
84. FERREIRA PM, Machado F, Coelho DB, Alexandre AT, et al
    Clinical impact of pre-determined guideline selection for the diagnosis of fibrotic hypersensitivity pneumonitis.
    Respir Med. 2024 Dec 31:107925. doi: 10.1016/j.rmed.2024.107925.
    PubMed     Abstract available
    
    
    
85. BELHASSEN M, Marchal C, Deygas F, Jacoud F, et al
    In patients with asthma, obesity status is associated with poor control and high exacerbation rates, which are reversed after bariatric surgery.
    Respir Med. 2024;236:107917.
    PubMed     Abstract available
    
    
    
86. AJAZ M, Singh I, Vugic L, Jani R, et al
    The interplay of plant-based antioxidants, inflammation, and clinical outcomes in asthma: A systematic review.
    Respir Med. 2024;236:107918.
    PubMed     Abstract available
    
    
    
87. SHALMON T, Freund O, Wand O, Schneer S, et al
    Hypersensitivity Pneumonitis Radiologic Features in Interstitial Lung Diseases.
    Respir Med. 2024 Dec 2:107901. doi: 10.1016/j.rmed.2024.107901.
    PubMed     Abstract available
    
    
    
88. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
    Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
    Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
    PubMed     Abstract available
    
    
    
89. PETAT H, Marguet C
    Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study.
    Respir Med. 2024;235:107875.
    PubMed     Abstract available
    
    
    November 2024
90. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
    Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
    Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
    PubMed     Abstract available
    
    
    
91. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
    End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
    Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
    PubMed     Abstract available
    
    
    
92. YIGIT E, Yuksel H, Ulman C, Yilmaz O, et al
    NASAL EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE IN CHILDREN WITH ALLERGIC RHINITIS.
    Respir Med. 2024 Nov 27:107886. doi: 10.1016/j.rmed.2024.107886.
    PubMed     Abstract available
    
    
    
93. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
    Factors associated with uncontrolled severe asthma in the biologic era.
    Respir Med. 2024;236:107881.
    PubMed     Abstract available
    
    
    
94. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
    Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
    Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
    PubMed     Abstract available
    
    
    
95. SESHADRI N, Faig W, Young LR, Hill DA, et al
    Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
    Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
    PubMed     Abstract available
    
    
    
96. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
    Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
    Respir Med. 2024;234:107853.
    PubMed     Abstract available
    
    
    
97. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
    Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
    Respir Med. 2024;233:107779.
    PubMed     Abstract available
    
    
    
98. EASTERLING R, James WE
    Overlap syndromes in sarcoidosis: Unveiling the masquerader.
    Respir Med. 2024;234:107841.
    PubMed     Abstract available
    
    
    October 2024
99. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
    beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
    Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
    PubMed     Abstract available
    
    
    
100. WULFECK MK, Mummy DG, Zhang S, Kadi D, et al
     Hyperpolarized (129)Xe MRI and spectroscopy of gas exchange abnormalities in chronic hypersensitivity pneumonitis.
     Respir Med. 2024;234:107827.
     PubMed     Abstract available
     
     
     
101. ZHENG K, Tang L, Wang X, Chen L, et al
     The risk factors for chronic cough in children: A meta-analysis covering five continents.
     Respir Med. 2024;232:107752.
     PubMed     Abstract available
     
     
     
102. WU WW
     Association of naples prognostic score and lung health: A population-based study.
     Respir Med. 2024;232:107751.
     PubMed     Abstract available
     
     
     September 2024
103. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
     High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
     Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
     PubMed     Abstract available
     
     
     
104. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
     Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
     Respir Med. 2024;234:107808.
     PubMed     Abstract available
     
     
     
105. NOPSOPON T, Brown A, Hahn G, Rank M, et al
     Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
     Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
     PubMed     Abstract available
     
     
     
106. QUEZADA WA, Angulo D, Murray S, Joo M, et al
     Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
     Respir Med. 2024;231:107695.
     PubMed     Abstract available
     
     
     August 2024
107. WHARTON R, Mathis N, Wang JG, Meislin R, et al
     Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
     Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
     PubMed    
     
     
     
108. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
     Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
     Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
     PubMed     Abstract available
     
     
     
109. NORWEG A, Oh C, Nolan A
     Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
     Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
     PubMed    
     
     
     
110. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
     Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
     Respir Med. 2024;230:107693.
     PubMed     Abstract available
     
     
     July 2024
111. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
     Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
     Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
     PubMed     Abstract available
     
     
     
112. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
     The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
     Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
     PubMed     Abstract available
     
     
     
113. SORIANO JB, Polverino F
     Sexual activity and respiratory disease: A systematic review.
     Respir Med. 2024;228:107665.
     PubMed     Abstract available
     
     
     June 2024
114. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
     Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
     Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
     PubMed     Abstract available
     
     
     
115. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
     Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
     Respir Med. 2024;231:107714.
     PubMed     Abstract available
     
     
     
116. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
     A soft systems approach of asthma management in children based on therapeutic education and e-learning.
     Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
     PubMed     Abstract available
     
     
     
117. SMITH H, Easterling R, Ma J, Moodabagil M, et al
     Sarcoid-like reactions to immune checkpoint inhibitors: Incidence, treatment course, and impact on cancer progression and survival.
     Respir Med. 2024;227:107640.
     PubMed     Abstract available
     
     
     
118. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
     Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
     Respir Med. 2024;227:107638.
     PubMed     Abstract available
     
     
     May 2024
119. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
     Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
     Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
     PubMed     Abstract available
     
     
     
120. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
     The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
     Respir Med. 2024;226:107609.
     PubMed    
     
     
     
121. VAN WOENSEL J, Koopman B, Schiefer M, van Kan C, et al
     Organ involvement in newly diagnosed sarcoidosis patients in the Netherlands: The first large European multicentre prospective study.
     Respir Med. 2024;226:107608.
     PubMed     Abstract available
     
     
     
122. HARPER LJ, Tauquir A, Huang S, Wang X, et al
     Comparison of organ involvement clusters in Black and White American sarcoidosis patients from a prospectively collected patient registry.
     Respir Med. 2024;226:107605.
     PubMed     Abstract available
     
     
     April 2024
123. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
     Are biologics effective on lung hyperinflation in patients with resistant asthma?
     Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
     PubMed    
     
     
     
124. CAZZOLA M, Maniscalco M
     Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
     Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
     PubMed    
     
     
     
125. JI H, Tan LD, Hafzella G, Nguyen N, et al
     Navigating Biologic Therapies in Elderly Asthma.
     Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
     PubMed     Abstract available
     
     
     
126. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
     Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
     Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
     PubMed     Abstract available
     
     
     
127. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
     Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
     Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
     PubMed     Abstract available
     
     
     
128. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
     Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
     Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
     PubMed     Abstract available
     
     
     
129. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
     The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
     Respir Med. 2024;224:107564.
     PubMed     Abstract available
     
     
     
130. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
     Predicting exacerbations in COPD in the Danish general population.
     Respir Med. 2024;224:107557.
     PubMed     Abstract available
     
     
     
131. KOH LHL, Sims JL, Pepin F, Wilsher M, et al
     Role of screening for uveitis in subjects with sarcoidosis.
     Respir Med. 2024;224:107562.
     PubMed     Abstract available
     
     
     
132. DE BORTOLI A, Dawson KA, Hashem D, Spence SD, et al
     Screening tools for the detection of clinically silent cardiac sarcoidosis.
     Respir Med. 2024;224:107538.
     PubMed     Abstract available
     
     
     
133. XU X, Yin J, Yang Y, Liu H, et al
     Advances in co-pathogenesis of the united airway diseases.
     Respir Med. 2024;225:107580.
     PubMed     Abstract available
     
     
     March 2024
134. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
     A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
     Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
     PubMed     Abstract available
     
     
     
135. JEONG J, Nam YH, Sim DW, Kim BK, et al
     Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
     Respir Med. 2024;225:107598.
     PubMed     Abstract available
     
     
     
136. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
     Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
     Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
     PubMed     Abstract available
     
     
     February 2024
137. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
     Impact of biologics on lung hyperinflation in patients with severe asthma.
     Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
     PubMed     Abstract available
     
     
     
138. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
     No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
     Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
     PubMed     Abstract available
     
     
     January 2024
139. PAPI A, Castro M, Corren J, Pavord ID, et al
     Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
     Respir Med. 2024 Jan 23:107535. doi: 10.1016/j.rmed.2024.107535.
     PubMed     Abstract available
     
     
     November 2023
140. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
     A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
     Respir Med. 2023;219:107435.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.